Why BrainStorm Cell Therapeutics Blasted 27.7% Higher Today
1 minuto de lectura
What happenedBrainStorm Cell Therapeutics’ (NASDAQ: BCLI) stock price shot up by nearly 30% today, on the one-two punch of an encouraging metric or two in its quarterly results and an update about its most promising pipeline drug.Read MoreMarketsMarkets Feed
Descubre más desde Espacioteca
Suscríbete y recibe las últimas entradas en tu correo electrónico.
